Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Deficit (Details)

v3.24.1.1.u2
Stockholders’ Deficit (Details) - USD ($)
 1 Months Ended 3 Months Ended
Jul. 11, 2023
Jul. 31, 2021
Mar. 31, 2024
Dec. 31, 2023
Stockholders’ (Deficit) Equity [Line Items]        
Common stock, shares authorized     200,000,000 200,000,000
Common stock, par value (in Dollars per share)     $ 0.001 $ 0.001
Shares issued 19,516,205      
Exchange for cash price, per unit (in Dollars per share)   $ 5    
Shares of common stock 43,649   736,773  
Convertible debt shares granted     184,193  
Warrant [Member]        
Stockholders’ (Deficit) Equity [Line Items]        
Shares issued   4,000,000    
Exercise price per warrant (in Dollars per share)   $ 0.0125 $ 6  
Warrants term   5 years 5 years  
Exercise price per share (in Dollars per share)   $ 6 $ 1,000  
Purchase of additional warrants   600,000    
Proceeds of warrants (in Dollars)   $ 7,500    
Common Stock [Member]        
Stockholders’ (Deficit) Equity [Line Items]        
Common stock price, per share (in Dollars per share)   $ 4.99    
Auto-conversion of the series A preferred stock 19,516,205      
Series A-2 Preferred Stock [Member]        
Stockholders’ (Deficit) Equity [Line Items]        
Auto-conversion of the series A preferred stock 43,649      
IPO [Member]        
Stockholders’ (Deficit) Equity [Line Items]        
Issuance of common shares   5,000,000